How much capital did Rocket Lab raise and when does the offering close?

Rocket Lab priced $300.0 million of convertible senior notes on February 1, 2024, with estimated net proceeds of about $290.2 million. The offering was expected to close on February 6, 2024, subject to customary conditions. The initial purchasers have a 13-day option for up to $55.0 million more, which would raise net proceeds to about $343.5 million.

At what stock price would the notes convert, and how does that compare to the market?

The initial conversion price is about $5.13 per share, a premium of roughly 27.5% over the $4.02 closing price on February 1, 2024. Conversion would be economically attractive to holders only if the stock rises above that level. The conversion rate and price may adjust for certain corporate events.

What are the capped call transactions and how do they protect shareholders?

Capped calls are privately negotiated options with financial institutions that are designed to reduce or offset dilution when notes convert, up to a cap price of $8.04 per share, a 100% premium to the reference price. They cost about $36.5 million of the offering's net proceeds. They can also offset cash payments above principal on conversion, subject to the cap. They do not eliminate dilution above $8.04.

How will Rocket Lab use the money?

About $36.5 million will fund the capped call transactions and about $40 million will repay part of the borrowings under its equipment financing agreement, including accrued interest. The remainder is for working capital and general corporate purposes, which may include potential acquisitions and strategic transactions.

When can holders convert and when can Rocket Lab redeem the notes?

Before November 1, 2028, holders may convert only in certain circumstances and during specified periods. From November 1, 2028 until the second scheduled trading day before maturity, they may convert at any time. Rocket Lab may redeem the notes for cash on or after February 1, 2027, but only if the stock exceeds 130% of the conversion price for a specified period and certain liquidity conditions are satisfied.

RKLB 8-K SEC Disclosure

01—Abstract

Summary

Summary of the 8-K filed February 2, 2024. Cited figures are marked; the original filing is the authoritative source.

On February 1, 2024, Rocket Lab USA (Nasdaq: RKLB) priced an upsized private offering of $300.0 million^a of 4.250% convertible senior notes due February 1, 2029, up from the $275.0 million initially announced on January 31.

The initial purchasers also received a 13-day option to buy up to an additional $55.0 million^b of notes. The offering was expected to close on February 6, 2024. Estimated net proceeds are about $290.2 million, or about $343.5 million if the option is exercised in full.

The notes are senior, unsecured obligations with an initial conversion rate of 195.1029 shares per $1,000^c principal, or about $5.13 per share. That price is a roughly 27.5% premium to the $4.02 closing price on February 1, 2024. Rocket Lab may settle conversions in cash, shares, or a combination.

The company also entered into capped call transactions with a cap price of $8.04^d per share, a 100% premium to the reference price, to reduce potential dilution. About $36.5 million of proceeds will fund the capped calls. Roughly $40 million will repay part of the borrowings under its equipment financing agreement, and the remainder goes to working capital and general corporate purposes, including potential acquisitions.

For investors, the transaction adds meaningful liquidity and refinances some higher-cost equipment debt, while the convertible structure defers equity dilution until the stock trades above about $5.13, with the capped calls offsetting dilution up to $8.04. The filing does not disclose the company's cash position, operating results, or the fiscal 2023 financial statements, so the notes should be evaluated alongside those disclosures and the risks in the Form 10-K. Note also that the January 31 release referenced a $41.25 million option, which was superseded by the $55.0 million option in the February 1 pricing release.

02—Key points

Key Highlights

Upsized offering: $300.0 million of 4.250% convertible senior notes due 2029, increased from the initially announced $275.0 million, with a $55.0 million over-allotment option exercisable within 13 days.
Conversion price of approximately $5.13 per share (195.1029 shares per $1,000 principal), a 27.5% premium to the $4.02 closing price on February 1, 2024.
Capped call transactions with a cap price of $8.04 per share (100% premium) to offset dilution from conversions, costing about $36.5 million of net proceeds.
Estimated net proceeds of approximately $290.2 million, rising to about $343.5 million if the option is fully exercised.
About $40 million of proceeds will repay part of the equipment financing agreement borrowings, including accrued interest.
Remaining proceeds are for working capital, general corporate purposes, and potential acquisitions and strategic transactions.
Rocket Lab may settle conversions in cash, common stock, or a combination, and may redeem the notes on or after February 1, 2027 if the stock exceeds 130% of the conversion price and liquidity conditions are met.

03—Questions

Frequently Asked Questions

How much capital did Rocket Lab raise and when does the offering close?
Rocket Lab priced $300.0 million of convertible senior notes on February 1, 2024, with estimated net proceeds of about $290.2 million. The offering was expected to close on February 6, 2024, subject to customary conditions. The initial purchasers have a 13-day option for up to $55.0 million more, which would raise net proceeds to about $343.5 million.
At what stock price would the notes convert, and how does that compare to the market?
The initial conversion price is about $5.13 per share, a premium of roughly 27.5% over the $4.02 closing price on February 1, 2024. Conversion would be economically attractive to holders only if the stock rises above that level. The conversion rate and price may adjust for certain corporate events.
What are the capped call transactions and how do they protect shareholders?
Capped calls are privately negotiated options with financial institutions that are designed to reduce or offset dilution when notes convert, up to a cap price of $8.04 per share, a 100% premium to the reference price. They cost about $36.5 million of the offering's net proceeds. They can also offset cash payments above principal on conversion, subject to the cap. They do not eliminate dilution above $8.04.
How will Rocket Lab use the money?
About $36.5 million will fund the capped call transactions and about $40 million will repay part of the borrowings under its equipment financing agreement, including accrued interest. The remainder is for working capital and general corporate purposes, which may include potential acquisitions and strategic transactions.
When can holders convert and when can Rocket Lab redeem the notes?
Before November 1, 2028, holders may convert only in certain circumstances and during specified periods. From November 1, 2028 until the second scheduled trading day before maturity, they may convert at any time. Rocket Lab may redeem the notes for cash on or after February 1, 2027, but only if the stock exceeds 130% of the conversion price for a specified period and certain liquidity conditions are satisfied.

04—Continue

← View all 8-K filings